Non-Serious Adverse Events
If YES, indicate following items. Any untoward medical occurrence in a patient or clinical investigation subject, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a medicinal product. For marketed medicinal products, this also includes failure to produce expected benefits (i.e., lack of efficacy), abuse or misuse.
text
Diagnosis only (if known) signs / symptoms (list one per line). Enter only the diagnosis (if known); otherwise each sign and symptom should be entered on a separate line If a diagnosis subsequently becomes available, then this should be entered and the signs and symptoms crossed out.
text
day month year. Record the date of onset of the first occurrence of the AE .
date
00:00-23:59 Record the exact time of onset of the AE.
time
Record the maximum intensity that occurred over the duration of the event. Amend the intensity if it increases.
text
All AEs must be followed until the events are resolved, the condition stabilizes, the events are otherwise explained, or the subject is lost to follow-up. Indicate if the event was "Resolved" or "Resolved with sequelae". If the adverse event is ongoing at the time the subject completes the study or becomes lost to follow-up, the outcome must be recorded as "Not resolved". Also enter "Not resolved" if the AE was ongoing at the time of death, but was not the cause of death.
text
day month year. Record the date of resolution. This is the last date of occurrence of the AE. If the event resolved with sequelae, enter the date the subject's medical cond ition stabilized. Leave blank if the AE is "Not resolved".
date
00:00-23:59 Record the exact lime of resolution of the AE.
time
Indicate only for the specific event(s) that were directly responsible for the action taken with investigational product(s): None: lnvestigational product(s) continue(s) even though an adverse event has occurred. Dose adjusted: Dose is increased or decreased for one or more investigation al product(s). Temporarily interrupted: Administration of one or more invesligational product(s) was stopped temporarily but then restarted. Permanently discontinued: Administration of one or more investigalional product(s) was stopped permanently and not restarted. Not applicable: Subject was not receiving investigational product(s) when the event occurred (e.g., pre- or postdosing).
text
Indicate only the event(s) directly responsible for the subject's withdrawal as indicated on the End of Study Record page.
text
II is a regulatory requirement for investigators lo assess relationship lo invesligalional product(s) based on information available. The assessment should be reviewed on receipt of any new information and amended if necessary. "A reasonable possibility" is meant to convey that there are facts/evidence or arguments to suggest a causal relationship. Facts/evidence/arguments that may support ''A reasonable possibility" include , for example, a temporal relationship, a pharmacologically-predicted event, or positive dechallenge or rechallenge Confounding factors, such as concomitant medication, a concomitant illness, or relevant medical history, should also be considered.
text
If you tick YES, fill in the SAE form!
text